Oncolytics Biotech, Inc. (ONCY) Q1 2025 Earnings
ONCY·Reported May 14, 2025·After market close
Diluted EPS came in at $-0.06 (+14.3% YoY), beat the $-0.09 consensus by $0.03.
Diluted EPS
$-0.06beat by $0.03
Consensus: $-0.09
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about Oncolytics Biotech, Inc.'s Q1 2025 earnings report.
Oncolytics Biotech, Inc. (ONCY) reported Q1 2025 earnings on May 14, 2025 after market close.
Oncolytics Biotech, Inc. reported diluted EPS of $-0.06 for Q1 2025.
EPS beat the consensus estimate of $-0.09 by $0.03.
Compared to the same quarter a year prior, diluted EPS grew 14.3% from $-0.07.